11.2 Replacements, Parity, and Medicare Marketing

Replacement Regulations

A replacement is any transaction in which new insurance or an annuity is to be purchased, and as a result, the applicant will lapse, forfeit, surrender, or convert an existing policy, or the existing policy will be reduced in value, amended, or otherwise modified. Replacement is lawful when it is suitable and fully disclosed, but states require producers to follow replacement notice procedures so the applicant makes an informed decision.

Under the NAIC Model Replacement Regulation (adopted in most states with local variations), the producer must:

1. Present a Notice of Replacement to the applicant and obtain a signed acknowledgment.
2. Leave with the applicant a copy of all sales materials and the replacement notice.
3. Provide a comparison statement summarizing the key features — premium, benefits, surrender charges, and nonforfeiture values — of the existing and proposed policies.
4. List every policy to be replaced.
5. Submit the replacement notice (and comparison) to the existing insurer, which then has a duty to attempt to conserve the policy by contacting the insured.
6. Apply a free-look period that is typically at least 30 days (longer in some states and for seniors) on the new policy.

The regulation applies to life, annuity, disability income, and Medicare Supplement replacements; many states extend special rules to seniors (e.g., longer free-look, heightened suitability). For A&H producers, the most-tested replacement is the Medicare Supplement replacement, which carries an enhanced notice and, in some states, a replacement only when the insured receives equal or greater benefits for equal or lower premium.

Suitability

Replacement regulations increasingly layer a suitability requirement on the producer: the producer must have a reasonable basis to believe the recommended replacement is suitable for the insured based on the insured's age, health, financial situation, and coverage needs. A replacement that pays higher commission but increases cost or reduces benefits without an offsetting client advantage is presumptively unsuitable.

MHPAEA — Mental Health Parity and Addiction Equity Act

The Mental Health Parity and Addiction Equity Act (MHPAEA), as amended by the ACA, requires that financial requirements (deductibles, copayments, coinsurance, out-of-pocket maximums) and treatment limits (visit, day, or stay limits) applied to mental health and substance use disorder (MH/SUD) benefits be no more restrictive than the most restrictive comparable level applied to substantially all medical/surgical benefits in the same classification.

The six benefit classifications under MHPAEA are:

1. Inpatient, in-network
2. Inpatient, out-of-network
3. Outpatient, in-network
4. Outpatient, out-of-network
5. Emergency care
6. Prescription drugs

Within each classification, the parity analysis tests financial requirements and quantitative treatment limits by comparing the MH/SUD level to the medical/surgical level, and separately tests non-quantitative treatment limits (NQTLs) — such as prior authorization, medical necessity standards, step therapy, and network adequacy — for comparability in design and application. The Consolidated Appropriations Act of 2021 added the NQTL comparative analyses requirement: plans must prepare and, on request, provide to regulators, participants, and providers written comparative analyses demonstrating that NQTLs for MH/SUD are no more restrictive than for medical/surgical.

MHPAEA does not require a plan to cover any particular MH/SUD benefit — it only requires parity if the benefit is covered. The ACA's Essential Health Benefits, however, do require individual and small-group plans to cover MH/SUD as one of the 10 EHB categories, so for those markets MH/SUD coverage is mandatory and parity applies to it.

Medicare Marketing Rules (CMS)

The CMS Medicare Communications and Marketing Guidelines (MCMG) govern how Medicare Advantage (Part C) and Medicare Part D plans, and the agents and brokers who sell them, may communicate with and solicit beneficiaries. The 2024+ revisions tightened several rules in response to abusive marketing.

Scope of Appointment (SOA)

Before any personal marketing appointment (in person or telephonic), the producer must obtain a signed Scope of Appointment (SOA) form that documents which product types the beneficiary wishes to discuss. The SOA must be obtained at least 48 hours before the appointment (or, if the appointment occurs within 48 hours of the beneficiary's initiation, the 48-hour wait is waived but the SOA is still required). During the appointment, the producer may only discuss the product types listed on the SOA unless the beneficiary signs a new SOA.

Unsolicited Contacts and Door-to-Door

CMS prohibits:

• Door-to-door marketing — uninvited in-person solicitation, including leaving flyers or brochures at a beneficiary's door, is prohibited.
• Unsolicited telephone contacts — cold calling to market Medicare plans without the beneficiary's prior express consent.
• Approaching beneficiaries in common areas of health care settings (waiting rooms, parking lots, pharmacies) or at educational events.

Permitted contacts include: educational events (no sales or plan-specific marketing, no on-site enrollment), personal/one-on-one appointments scheduled by the beneficiary, and marketing in response to the beneficiary's inbound request. A producer may business reply to an inbound request within defined limits.

Third-Party Marketing Organizations (TPMOs)

TPMOs are entities that perform marketing, lead generation, or enrollment functions for Medicare plans but are not themselves the plan. TPMOs must comply with the same CMS marketing rules and must disclose in their marketing materials that they are not connected with or endorsed by the U.S. government or Medicare. Agents using TPMOs remain responsible for supervising the TPMO's conduct and may be held accountable for TPMO violations.

Compensation Limits

CMS sets and periodically adjusts agent/broker compensation rules for Medicare Advantage and Part D enrollment. Compensation is capped and structured as an initial enrollment compensation plus a renewal compensation that may not exceed the initial amount for the life of the enrollment; renewals may be reduced by a documented service failure. Producers may not receive compensation that is conditioned on disenrollment or that is so high as to create an inducement to churn enrollees between plans.

ACA Section 1557 — Nondiscrimination

Section 1557 of the ACA prohibits discrimination on the basis of race, color, national origin, sex, age, or disability in any health program or activity, any part of which receives federal financial assistance (including Medicare and Marketplace subsidies), or is administered by an executive agency (HHS). Section 1557's protections extend to marketing and enrollment: a producer cannot steer applicants away from a plan because of a protected characteristic, and plan materials must be accessible and available in the top languages spoken in the service area. The 2024 final rule reinstated protections on the basis of gender identity and sexual orientation as part of "sex" discrimination.

Interplay of the Three Regimes

A producer selling a Medicare Supplement replacement to a 68-year-old must satisfy all three regimes simultaneously: (1) state replacement notice and suitability, (2) MHPAEA parity is built into any ACA plan being compared, and (3) CMS marketing rules govern how the appointment was set. A single violation in any layer is a violation of the whole, and the most restrictive rule governs when regimes overlap.